Transvesical Versus Posterior Approach to Retzius-Sparing Robot-Assisted Radical Prostatectomy: A Retrospective Comparison With a 12-Month Follow-Up.
Transvesical Versus Posterior Approach to Retzius-Sparing Robot-Assisted Radical Prostatectomy: A Retrospective Comparison With a 12-Month Follow-Up.
复制标题
经膀胱与后路入路保留 Retzius 机器人辅助根治性前列腺切除术：与 12 个月随访的回顾性比较
DOI：
10.3389/fonc.2021.641887
复制
发表时间：
2021
影响因子：
4.7
通讯作者：
Wang G
中科院分区：
文献类型：
--
作者：
Deng W;Zhang C;Jiang H;Li Y;Zhu K;Liu X;Chen L;Liu W;Guo J;Zhou X;Fu B;Wang G
评估经膀胱机器人辅助根治性前列腺切除术（T-RARP）和后路机器人辅助根治性前列腺切除术（P-RARP）治疗局限性前列腺癌的围手术期、功能和肿瘤学结局。我们以回顾性方式分析了2017年1月至2019年6月期间接受T-RARP或P-RARP治疗局限性前列腺癌的96例患者的数据。T-RARP和P-RARP组之间的基线特征无显著差异。两组均成功进行了两种干预，未发生开放性转换。T-RARP的手术时间（135.3 vs. 127.3 min）和估计失血量（105.2 vs. 94.2 mL）略长于P-RARP，但差异不显著（均p > 0.05）。T-RARP组中输血、≤ II级和> II级术后并发症、pT 3a疾病和手术切缘阳性的可能性与P-RARP组相当。两组之间在导管移除和导管脱落时的UC方面无显著差异（分别为p = 0.750和p = 0.684），所有入选患者均在术后3个月恢复UC。两组的国际勃起功能指数-5评分中位数在RARP前后保持可比性。T-RARP和P-RARP组的患者具有相似的生化无复发生存率（p = 0.387）。由经验丰富的医生进行的T-RARP和P-RARP对于精心选择的前列腺癌患者都是可行的，在围手术期结果、UC和勃起功能以及短期随访内的肿瘤控制方面获得了相似的结局。
To assess the perioperative, functional, and oncological outcomes of transvesical robot-assisted radical prostatectomy (T-RARP) and posterior robot-assisted radical prostatectomy (P-RARP) for localized prostate cancer. We analyzed the data of 96 patients who underwent T-RARP or P-RARP for localized prostate cancer between January 2017 and June 2019 in a retrospective fashion. No significant differences in the baseline characteristics existed between the T-RARP and P-RARP arms. Both interventions were successfully performed without open conversion in either group. T-RARP was associated with a slightly more operative time (135.3 vs. 127.3 min) and estimated blood loss (105.2 vs. 94.2 mL) than P-RARP, but the differences were not significant (both p > 0.05). The likelihood of transfusion, ≤Grade II, and >Grade II postoperative complications, pT3a disease and positive surgical margins in the T-RARP group was comparable with that in the P-RARP group. No significant differences were noted between these two arms in terms of UC at the removal of catheter and nocturia (p = 0.750 and p = 0.684, respectively), and all included patients recovered UC at 3 months postoperatively. The median International Index of Erectile Function-5 score in both groups remains comparable before and after RARP. The patients in the T-RARP and P-RARP groups had a similar biochemical recurrence-free survival (p = 0.387). Both T-RARP and P-RARP by experienced hands are feasible for well-selected patients with prostate cancer, obtaining similar outcomes in terms of perioperative results, UC and erectile function, and oncological control within short-term follow-up.
登录
查看更多内容
DOI：
10.1056/nejmoa1311593
发表时间：
2014-03-06
期刊：
The New England journal of medicine
影响因子：
--
作者：
Bill-Axelson A;Holmberg L;Garmo H;Rider JR;Taari K;Busch C;Nordling S;Häggman M;Andersson SO;Spångberg A;Andrén O;Palmgren J;Steineck G;Adami HO;Johansson JE
通讯作者：
Johansson JE
影响因子：
23.4
作者：
Dalela, Deepansh;Jeong, Wooju;Menon, Mani
通讯作者：
Menon, Mani
影响因子：
23.4
作者：
Galfano, Antonio;Ascione, Assunta;Bocciardi, Aldo Massimo
通讯作者：
Bocciardi, Aldo Massimo
DOI：
10.1007/s00464-018-6499-z
发表时间：
2019-07-01
影响因子：
3.1
作者：
Asimakopoulos, Anastasios D.;Topazio, Luca;Annino, Filippo
通讯作者：
Annino, Filippo
影响因子：
2.1
作者：
Rosen, RC;Riley, A;Mishra, A
通讯作者：
Mishra, A